Oscar Della Pasqua
Overview
Explore the profile of Oscar Della Pasqua including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
116
Citations
899
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
van Dijkman S, Yorgancioglu A, Pavord I, Brusselle G, Pitrez P, Oosterholt S, et al.
Adv Ther
. 2024 Jan;
41(3):1201-1225.
PMID: 38296921
Introduction: Even though increased use of reliever medication, including short-acting beta agonists (SABA), provides an indirect measure of symptom worsening, there have been limited efforts to assess how different patterns...
12.
Sethi V, Qin L, Cox E, Troconiz I, Della Pasqua O
Pain Ther
. 2024 Jan;
13(1):145-159.
PMID: 38183573
Introduction: Acetaminophen and topical diclofenac (AtopD) have complementary mechanisms of action and are therefore candidates for combination use in osteoarthritis (OA) pain. However, an evidence gap exists on their combination...
13.
Sethi V, Qin L, Troconiz I, Van der Laan L, Cox E, Della Pasqua O
Pain Ther
. 2024 Jan;
13(1):127-143.
PMID: 38183572
Introduction: The use of combination therapy of oral acetaminophen and topical diclofenac, having complementary mechanisms of action, is an attractive strategy to enhance the analgesic response in osteoarthritis (OA) pain....
14.
Healy P, Verrest L, Felisi M, Ceci A, Della Pasqua O
Pharmacol Res Perspect
. 2023 Oct;
11(5):e01138.
PMID: 37803937
Despite off-label use, the efficacy and safety of gabapentin and tramadol in pediatric patients (3 months to <18 years old) diagnosed with chronic pain has not been characterized. However, generating...
15.
Singh D, Oosterholt S, Pavord I, Garcia G, Pg A, Della Pasqua O
Adv Ther
. 2023 Aug;
40(10):4606-4625.
PMID: 37589831
Introduction: The assessment of future risk has become an important feature in the management of patients with asthma. However, the contribution of patient-specific characteristics and treatment choices to the risk...
16.
Oosterholt S, Pavord I, Brusselle G, Yorgancioglu A, Pitrez P, Pg A, et al.
Br J Clin Pharmacol
. 2023 May;
89(11):3273-3290.
PMID: 37221636
Aims: There is limited understanding of how clinical and demographic characteristics are associated with exacerbation risk in patients with moderate-to-severe asthma, and how these factors correlate with symptom control and...
17.
Papassidero P, Wichert-Ana L, Lia E, Alexandre-Santos L, Trevisan A, Coelho E, et al.
Reg Anesth Pain Med
. 2023 Mar;
48(8):408-413.
PMID: 37001886
Background: Gabapentin is an effective therapeutic alternative for chronic low back pain, indicated in several guidelines for treating neuropathic pain as first-line medication. This study aimed to describe the pharmacodynamics...
18.
Musuamba F, Cheung S, Colin P, Davies E, Barret J, Pappalardo F, et al.
Clin Pharmacol Ther
. 2023 Jan;
114(1):41-50.
PMID: 36708100
The most intuitive question for market access for medicinal products is the benefit/risk (B/R) balance. The B/R assessment can conceptually be divided into subquestions related to establishing efficacy and safety....
19.
Lia E, Papassidero P, Coelho E, Dach F, Alexandre-Santos L, Trevisan A, et al.
Eur J Hybrid Imaging
. 2022 Nov;
6(1):26.
PMID: 36404393
Background: Recent neuroimaging studies have demonstrated pathological mechanisms related to cerebral neuroplasticity in chronic low back pain (CLBP). Few studies have compared cerebral changes between patients with and without pain...
20.
Johnson R, Saez-Lopez E, Anagonou E, Kpoton G, Ayelo A, Gnimavo R, et al.
Trials
. 2022 Jul;
23(1):559.
PMID: 35804454
Background: Buruli ulcer (BU) is a neglected tropical disease caused by Mycobacterium ulcerans that affects skin, soft tissues, and bones, causing long-term morbidity, stigma, and disability. The recommended treatment for...